奥司他韦
医学
大流行
肺炎
H5N1的传播和感染
H5N1亚型流感病毒
流感大流行
H5N1导致的人类死亡率
重症监护医学
大流行性流感
抗生素
病毒学
内科学
2019年冠状病毒病(COVID-19)
病毒
疾病
传染病(医学专业)
微生物学
禽流感病毒
生物
标识
DOI:10.1517/14656566.6.14.2493
摘要
AbstractSeasonal influenza causes significant morbidity and mortality in adults and children. However, a worldwide influenza pandemic could cause considerably more deaths (20 – 40 million) and would majorly disrupt everyday life in most countries. Oseltamivir has proven to be safe and effective for the prevention or treatment of all known influenza subtypes, reducing the severity and duration of symptoms, the complications arising from influenza infection (pneumonia, hospitalisation, antibiotic use) and mortality. Oseltamivir has been shown to be effective against pandemic strains of influenza, including the currently circulating strain (H5N1). As a result, the World Health Organization has recommended the stockpiling of oseltamivir in the event of an influenza pandemic.Keywords:: epidemicinfluenzaoseltamivirpandemic
科研通智能强力驱动
Strongly Powered by AbleSci AI